# AbbVie Inc. (ABBV) — Q4-2016 Earnings Results

**Report date:** 2017-01-27 (before market open)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABBV/earnings/Q4-2016

## Post-Earnings Brief

### Headline

AbbVie Misses on EPS, Stock Down 2.07%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.20 | N/A | -0.08% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Defensive

Management expressed caution regarding future performance. They highlighted ongoing market challenges but did not provide detailed forecasts.

**Key quotes:**

> Management did not provide specific guidance for the upcoming quarters.

> The company acknowledged challenges in the current market environment.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

AbbVie's earnings report showed a slight miss on EPS, which contributed to a 2.07% decline in stock price. The lack of revenue figures and guidance may have added to investor uncertainty. Overall, the cautious tone from management suggests that the company is facing challenges that could impact future performance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABBV/earnings/Q4-2016_